Addressing the clinical void in spinal surgery
Kunovus is focused on one of the most important gaps in spine care: patients whose degenerative disc disease has progressed beyond conservative treatment, but for whom fusion may not be the ideal next step.
Our platform brings together implantable elastomeric disc technologies, dynamic stabilisation concepts, precision delivery systems and imaging augmentation.
RESTORE
Our technology platform
Injectable elastomeric implant designed to replace lost nucleus function and restore mechanical support within the disc space.
​
Addresses the mechanical source of disc degeneration, not just symptoms.
​
​Key assets: KDD-1, KDD-2
STABILISE
Dynamic stabilisation concepts designed to support the diseased spinal segment while preserving physiological movement.
​
Creates an alternative to spinal fusion that preserves motion and prevents further degradation in adjacent spinal regions.
Key assets: DIBS, Hsu-Lace
Advanced imaging technologies designed to support diagnosis, patient selection, anatomical targeting and reproducible treatment.
​
Designed to helps surgeons identify the right patients and improve outcomes.
​
Key assets: DeVa
VISUALISE
Development foundation
01 Protected technology
Multiple issued US patents protecting core spinal implant and delivery technologies
02 Biomechanical testing
Rigorous biomechanical testing, including fatigue, creep, shock and expulsion testing
03 Biocompatability work
Biocompatibility and toxicology studies completed in line with ISO 10993
04 Preclinical validation
Preclinical and cadaveric studies supporting surgical technique and device implantation
05 Clinical testing
First-in-human clinical experience completed with long-term follow-up for Kunovus Disc Device, DIS and PGA
06 Clinical ecosystem
Collaborations with spine surgeons, hospitals and research partners across Australia and internationally
Kunovus has built a substantial translational foundation across intellectual property, bench testing, preclinical validation, surgical workflow development and early human clinical experience.